Product: Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.
Reason for recall: CGMP Deviations: Presence of NDMA impurity detected in product.
Recall initiated: 20191001
Status: Completed
Classification: Class II
Recall type: Voluntary: Firm initiated